Understanding Stereochemistry: Why is Levobupivacaine Less Cardiotoxic than Bupivacaine?
•
5 min read
In the late 1970s, reports of severe cardiotoxicity and fatal outcomes associated with bupivacaine led to an intense focus on understanding its pharmacological properties and developing safer alternatives. Levobupivacaine emerged as a safer option due to fundamental differences in its chemical structure, which significantly reduces the risk of cardiac adverse effects compared to the racemic bupivacaine mixture.